Výsledky vyhledávání - "Alison P. McNabb"

Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data

Autor: John L. Bell, Alison P. McNabb, Amila Orucevic, Robert E. Heidel, Megan King

Publikováno v: The Breast. 46:116-125

Objectives Oncotype DX (ODX), 21-gene breast cancer (BC) assay, predicts risk of recurrence and benefits of addition of chemotherapy to hormonal therapy for early-stage BC. We previously published a nomogram/calculator that could predict ODX results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff74940a6342608e7367604b54f3d14
https://doi.org/10.1016/j.breast.2019.05.006

Zobrazit plný text záznamu

Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data

Autor: John L. Bell, Robert E. Heidel, Amila Orucevic, Alison P. McNabb

Publikováno v: Breast Cancer Research and Treatment

Purpose Oncotype DX (ODX) recurrence score (RS) breast cancer (BC) assay is costly, and performed in only ~1/3 of estrogen receptor (ER)-positive BC patients in the USA. We have now developed a user-friendly nomogram surrogate prediction model for OD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cefd3bc47adb72cc64d4b05ff09ec03
https://doi.org/10.1007/s10549-017-4170-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání